Showing results (271-280 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|January 30, 2025
Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System databaseLisi Xu, Ruonan Zhang, Xiaolin Zhang, et al.
Therapeutic Advances in Neurological Disorders|January 13, 2025
Identifying Cladribine prescription pattern in MS: an Italian multicentre studyAurora Zanghì, Roberta Fantozzi, Matteo Foschi, et al.
Therapeutic Advances in Neurological Disorders|January 13, 2025
An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control studyTongyang Niu, Peize Wang, Xiaomeng Zhou, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2024
First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case reportIsabelle Kwiedor, Martina Menacher, Monika Ellßel, et al.
Therapeutic Advances in Neurological Disorders|November 15, 2024
Short delay to initiate plasma exchange or immunoadsorption as synergistic therapies for patients in the acute phase of anti-NMDAR encephalitisMiao Su, Zichao Wu, Qiuyan Luo, et al.
Therapeutic Advances in Neurological Disorders|February 20, 2025
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypesLei Jin, Zhangyu Zou, Qinzhou Wang, et al.
Therapeutic Advances in Neurological Disorders|February 24, 2025
Sustained-release oral dalfampridine appears to have no impact on upper extremity function in people with multiple sclerosis: a randomized controlled trialShay Menascu, Lior Frid, Alon Kalron
Therapeutic Advances in Neurological Disorders|November 17, 2025
Comparative evaluation of STRATIFY JCV™ and IMMUNOWELL™ assays for anti-JCV antibody detection in natalizumab-treated RRMS patientsClara Grazia Chisari, Giulio Spampinato, Pina Crimì, et al.
Therapeutic Advances in Neurological Disorders|October 6, 2025
Increased middle cerebral artery velocity predicts malignant media infarction after endovascular stroke thrombectomyEnayatullah Baki, Victoria Kehl, Marlene Topka, et al.
Therapeutic Advances in Neurological Disorders|October 14, 2025
Time-series clustering analysis for treatment pattern of lasmiditan for 2 years from the initial prescriptionMasahito Katsuki, Yuya Yamada, Taisuke Ichihara, et al.
Pageof 108